Department of Dermatology, UC Davis, 3301 C Street, Suite 1400, Sacramento, CA, 95816, USA.
Drexel University College of Medicine, Philadelphia, PA, USA.
Am J Clin Dermatol. 2017 Dec;18(6):721-732. doi: 10.1007/s40257-017-0300-2.
BACKGROUND: Probiotic, prebiotic, and synbiotic supplementation is becoming more prevalent nowadays. Clinical studies have demonstrated some of the medical benefits of probiotics, prebiotics, and synbiotics within dermatology but an evidence-based review of their effects in adults is needed. OBJECTIVE: The aim of this study was to identify evidence for the use of supplementation with probiotics, prebiotics, or synbiotics for the prevention and treatment of dermatological diseases in adults. DATA SOURCES: We conducted a search of the Ovid MEDLINE, Cochrane Central Register of Controlled trials and EMBASE electronic databases from 1 January 1946 to 11 January 2017. STUDY SELECTION: Trials examining supplementation in the treatment of dermatological diseases using oral or topical probiotics, synbiotics, and prebiotics in adults over the age of 18 years were selected. DATA EXTRACTION: Of 315 articles, 12 met the inclusion criteria. DATA SYNTHESIS: Nutritional supplementation with probiotics and prebiotics was shown to improve atopic dermatitis (AD) symptomatology, quality of life, or clinical severity in six of nine studies. One study in psoriasis was shown to improve inflammatory markers, and one study suggested that probiotics could be used as adjunctive therapy in the treatment of acne. CONCLUSION: Preliminary studies are optimistic for the use of some strains of probiotics for symptomatic and clinical improvement in AD, and as adjunctive treatment with antibiotics for acne. Further research is necessary to better assess how probiotics and prebiotics may be used within dermatology.
背景:益生菌、益生元和合生剂的补充越来越普遍。临床研究已经证明了益生菌、益生元和合生剂在皮肤科中的一些医学益处,但需要对其在成年人中的作用进行基于证据的综述。
目的:本研究旨在确定补充益生菌、益生元或合生剂预防和治疗成年人皮肤科疾病的证据。
资料来源:我们对 Ovid MEDLINE、Cochrane 对照试验中央注册库和 EMBASE 电子数据库进行了搜索,检索时间为 1946 年 1 月 1 日至 2017 年 1 月 11 日。
研究选择:选择了使用口服或局部益生菌、合生剂和益生元治疗成人皮肤科疾病的补充试验,纳入对象为年龄在 18 岁及以上的成年人。
资料提取:在 315 篇文章中,有 12 篇符合纳入标准。
资料综合:有 9 项研究中的 6 项表明,营养补充益生菌和益生元可改善特应性皮炎(AD)症状、生活质量或临床严重程度。一项关于银屑病的研究表明可改善炎症标志物,一项研究表明益生菌可作为痤疮的辅助治疗。
结论:初步研究对于使用某些益生菌菌株改善 AD 的症状和临床改善以及作为抗生素辅助治疗痤疮持乐观态度。需要进一步研究以更好地评估益生菌和益生元如何在皮肤科中使用。
Am J Clin Dermatol. 2017-12
Probiotics Antimicrob Proteins. 2017-3
Nutrition. 2016-3
Eur Rev Med Pharmacol Sci. 2018-11
Nat Rev Gastroenterol Hepatol. 2020-11
Antioxidants (Basel). 2025-6-18
Front Microbiol. 2024-12-3
Microorganisms. 2024-10-3
Cochrane Database Syst Rev. 2024-10-23
Int J Mol Sci. 2024-4-24